BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17429140)

  • 1. p16 is consistently expressed in endometrial tubal metaplasia.
    Horree N; Heintz AP; Sie-Go DM; van Diest PJ
    Cell Oncol; 2007; 29(1):37-45. PubMed ID: 17429140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma.
    Horrée N; Gort EH; van der Groep P; Heintz AP; Vooijs M; van Diest PJ
    J Pathol; 2008 Jan; 214(1):38-45. PubMed ID: 17985331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia and angiogenesis in endometrioid endometrial carcinogenesis.
    Horrée N; van Diest PJ; van der Groep P; Sie-Go DM; Heintz AP
    Cell Oncol; 2007; 29(3):219-27. PubMed ID: 17452774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive derailment of cell cycle regulators in endometrial carcinogenesis.
    Horrée N; van Diest PJ; van der Groep P; Sie-Go DM; Heintz AP
    J Clin Pathol; 2008 Jan; 61(1):36-42. PubMed ID: 17483252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.
    Seeber LM; Horrée N; van der Groep P; van der Wall E; Verheijen RH; van Diest PJ
    BMC Cancer; 2010 Jun; 10():307. PubMed ID: 20565904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of COX-2, Ki-67, cyclin D1, and P21 in endometrial endometrioid carcinomas.
    Cao QJ; Einstein MH; Anderson PS; Runowicz CD; Balan R; Jones JG
    Int J Gynecol Pathol; 2002 Apr; 21(2):147-54. PubMed ID: 11917224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The invasive front in endometrial carcinoma: higher proliferation and associated derailment of cell cycle regulators.
    Horrée N; van Diest PJ; Sie-Go DM; Heintz AP
    Hum Pathol; 2007 Aug; 38(8):1232-8. PubMed ID: 17490724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis.
    Ruhul Quddus M; Latkovich P; Castellani WJ; James Sung C; Steinhoff MM; Briggs RC; Miranda RN
    Arch Pathol Lab Med; 2002 Apr; 126(4):459-63. PubMed ID: 11900573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.
    Ozbudak IH; Karaveli S; Simsek T; Erdogan G; Pestereli E
    Gynecol Oncol; 2008 Mar; 108(3):603-8. PubMed ID: 18191183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
    Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cell-cycle regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathologic parameters.
    Milde-Langosch K; Bamberger AM; Goemann C; Rössing E; Rieck G; Kelp B; Löning T
    J Cancer Res Clin Oncol; 2001 Sep; 127(9):537-44. PubMed ID: 11570574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary mucinous metaplasia of the endometrium as a possible precursor of endometrial mucinous adenocarcinoma.
    Yoo SH; Park BH; Choi J; Yoo J; Lee SW; Kim YM; Kim KR
    Mod Pathol; 2012 Nov; 25(11):1496-507. PubMed ID: 22766790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of the expression of cdk4 and p16INK4 in human endometrioid-type endometrial carcinoma.
    Shiozawa T; Nikaido T; Shimizu M; Zhai Y; Fujii S
    Cancer; 1997 Dec; 80(12):2250-6. PubMed ID: 9404701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
    Němejcová K; Rosmusová J; Bártů M; Důra M; Tichá I; Dundr P
    Int J Surg Pathol; 2017 Aug; 25(5):389-396. PubMed ID: 28381136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAX2 and cyclin D1 expression in the distinction between cervical microglandular hyperplasia and endometrial microglandular-like carcinoma: a comparison with p16, vimentin, and Ki67.
    Stewart CJ; Crook ML
    Int J Gynecol Pathol; 2015 Jan; 34(1):90-100. PubMed ID: 25473758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P16(INK4a) protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: diagnostic and clinical considerations.
    Caponio MA; Addati T; Popescu O; Petroni S; Rubini V; Centrone M; Trojano G; Simone G
    Cancer Biomark; 2014; 14(2-3):169-75. PubMed ID: 24878818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
    Bilyk OO; Pande NT; Buchynska LG
    Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.